Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2026

12 new medicines recommended for approval

EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its February 2026 meeting.

The committee recommended granting a marketing authorisation for mCombriax (influenza and…